Mastodawn

Agonist-Antagonist Myoneural Interface

https://www.media.mit.edu/projects/agonist-antagonist-myoneural-interface-ami/overview/

#HackerNews #Agonist-Antagonist #Myoneural #Interface #MIT #Media #Lab #Neural #Engineering #Bionics #Tech #Innovation

Project Overview ‹ Agonist-antagonist Myoneural Interface (AMI) – MIT Media Lab

Humans can accurately sense the position, speed, and torque of their limbs, even with their eyes shut. This sense, known as proprioception, allows humans to pr…

MIT Media Lab

mymedschool Nov 13

Drug effects depend on receptor binding, affinity, and intrinsic activity. #ReceptorBinding #Pharmacology #DrugAction #Affinity #IntrinsicActivity #Selectivity #Agonist #Antagonist #Pharmacodynamics #USMLE #MedicalEducation

https://mymedschool.org/portfolio/u01-05-008-receptor-binding/?utm_source=mastodon&utm_medium=jetpack_social

Competitive vs Non-Competitive Antagonism: Mastering Dose-Response Curves in Pharmacology

Learn how competitive antagonists affect drug potency and interpret dose-response curves. Understand high-yield pharmacology concepts for USMLE Step 1 and clinical reasoning in drug interactions.

mymedschool.org

Matt Willemsen Aug 15, 2023

'Triple G' Agonist Hits New Weight-Loss Heights
A novel triple agonist to receptors for three nutrient-stimulated hormones led to weight loss as high as 24% among people with overweight or obesity but who did not have type 2 diabetes when used at the highest tested dose for 48 weeks.
https://www.medscape.com/viewarticle/995316 #TripleG #Agonist #WeightLoss #hormones #obesity

'Triple G' Agonist Hits New Weight-Loss Heights

An editorial on phase 2 results from treating people with obesity or overweight but not diabetes with retatrutide, a triple hormone–receptor agonist, calls the weight loss achieved "unprecedented."

Medscape